title: Importance of angioedema-free days in patients with chronic idiopathic or spontaneous urticaria.
authors.affiliation: Genentech Inc, South San Francisco, California.
authors.forename: James L
authors.initials: JL
authors.lastname: Zazzali
authors.affiliation: Department of Medicine, Division of Pulmonary and Critical Care and Allergy and Clinical Immunology, University of South Carolina, Charleston, South Carolina.
authors.forename: Allen
authors.initials: A
authors.lastname: Kaplan
authors.affiliation: Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
authors.forename: Marcus
authors.initials: M
authors.lastname: Maurer
authors.affiliation: Genentech Inc, South San Francisco, California.
authors.forename: Karina
authors.initials: K
authors.lastname: Raimundo
authors.affiliation: Genentech Inc, South San Francisco, California.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Trzaskoma
authors.affiliation: Genentech Inc, South San Francisco, California. Electronic address: antonova.evgeniya@gene.com.
authors.forename: Evgeniya N
authors.initials: EN
authors.lastname: Antonova
authors.affiliation: Genentech Inc, South San Francisco, California.
authors.forename: Karin E
authors.initials: KE
authors.lastname: Rosén
mesh_terms: D000799:Angioedema; D006801:Humans; D000069444:Omalizumab; D014581:Urticaria
chemical_list: D000069444:Omalizumab